No spam - just the good stuff

Subscribe to our newsletter

News

Supplements

Delivering the goods – getting the best out of NMN supplements

NIH study shows elevating NAD+ with NR supplementation effectively reduces inflammation

NIH-funded longevity study shows astaxanthin extends lifespan

Research from Interventions Testing Program on astaxanthin represents advance in longevity supplements field.

Fatty acid C15:0 throws its hat into the longevity therapeutics ring

Fatty acid discovery is a fluke for longevity

Insilico and SRW partner to advance longevity science through power of AI

First global urolithin A summit set to highlight latest aging research

ChromaDex and Zesty Paws team up on cellular health for dogs

Are supplements the key to unlocking healthy longevity?

Avea and Lanserhof join forces to promote healthspan and longevity

Solgar Cellular Nutrition aims to take longevity cell deep

Mimio Health launches biomimetic based on the science of fasting to promote cellular health and longevity

Consumer longevity company Tally launches new daily supplement

NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market

First-ever clinical trial of ketone supplementation to treat and prevent frailty

Thorne to be acquired by L Catterton for $680 million in cash

Researchers develop compound that prevents free radical production in mitochondria

Avea secures $5 million in seed funding

Longevity: This time it’s personal

Taurine deficiency: New research identifies possible driver for aging

A strong patent portfolio delivers a competitive edge in the longevity space

Combilytics: Taking a combined approach to senescence

Longevity based on research, education and transparency

Mikra announces successful study results for CELLF

SRW – changing how we experience aging at a cellular level

Longevity supplements firm eyes pet longevity

Health organisations petition FDA to reverse its position on NMN supplements

Taking vitamin D could help prevent dementia, study finds

Researchers link supplement to reduced biomarkers of Alzheimer’s in the brain

New proprietary peptide product is easy on the eye

Off the shelves: Amazon bans NMN products

Muhdo 2.0 is taking personalized longevity to a new level

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.